BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35518389)

  • 1. Ultrasound-mediated delivery of RGD-conjugated nanobubbles loaded with fingolimod and superparamagnetic iron oxide nanoparticles: targeting hepatocellular carcinoma and enhancing magnetic resonance imaging.
    Guo XM; Chen JL; Zeng BH; Lai JC; Lin CY; Lai MY
    RSC Adv; 2020 Oct; 10(64):39348-39358. PubMed ID: 35518389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment.
    Guo X; Lin J; Pan L; He K; Huang Z; Chen J; Lin C; Zeng B; Luo S; Wang M
    Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):560-571. PubMed ID: 37850395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood-Brain Barrier Opening via Lipid-PLGA Nanobubbles.
    Yan Y; Chen Y; Liu Z; Cai F; Niu W; Song L; Liang H; Su Z; Yu B; Yan F
    Int J Nanomedicine; 2021; 16():7433-7447. PubMed ID: 34764649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
    Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
    Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
    Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
    Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
    Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer.
    Zou X; Jiang Z; Li L; Huang Z
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):83-95. PubMed ID: 33438446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
    Yang D; Chen Q; Zhang M; Feng G; Sun D; Lin L; Jing X
    Int J Nanomedicine; 2022; 17():4879-4894. PubMed ID: 36262190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Superparamagnetic Polymeric Micelles Loaded With Quercetin to Hepatocellular Carcinoma Cells.
    Srisa-Nga K; Mankhetkorn S; Okonogi S; Khonkarn R
    J Pharm Sci; 2019 Feb; 108(2):996-1006. PubMed ID: 30121312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH- and acoustic-responsive platforms based on perfluoropentane-loaded protein nanoparticles for ovarian tumor-targeted ultrasound imaging and therapy.
    Li J; Ji H; Jing Y; Wang S
    Nanoscale Res Lett; 2020 Feb; 15(1):31. PubMed ID: 32016619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles.
    Pathak V; Nolte T; Rama E; Rix A; Dadfar SM; Paefgen V; Banala S; Buhl EM; Weiler M; Schulz V; Lammers T; Kiessling F
    Biomaterials; 2021 Aug; 275():120896. PubMed ID: 34090049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles.
    Wang B; Wu W; Lu H; Wang Z; Xin H
    Front Pharmacol; 2018; 9():1556. PubMed ID: 30723412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
    Yu MK; Park J; Jeong YY; Moon WK; Jon S
    Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
    Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
    Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors.
    Li M; Kim HS; Tian L; Yu MK; Jon S; Moon WK
    Theranostics; 2012; 2(1):76-85. PubMed ID: 22272221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
    Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
    Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waterborne polyurethane magnetic nanomicelles with magnetically governed functions for breast cancer therapy.
    Mahdieh A; Yeganeh H; Motasadizadeh H; Nekoueifard E; Maghsoudian S; Hossein Ghahremani M; Nyström B; Dinarvand R
    Int J Pharm; 2023 Oct; 645():123356. PubMed ID: 37661033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.